Onsdag 28 Oktober | 21:02:23 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

OssDsign - Strengthening the balance sheet to take on next steps

2021-04-06 08:35:00

Redeye returns with a review of OssDsign following its announced rights issue and recently presented strategy update – ASCENT25. We are encouraged by its intensified focus on its neurosurgery product portfolio and its new, though adjacent, vertical in spine, strengthening our already favourable view on its longer-term prospects.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/